Secondaries announced 3.22.2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Celator Pharmaceuticals Symbol: CPXX Price: Last trade $10.01 Trade Date: 3/23 Shares: 3 million Underwriter(s) Stifel, Needham & Co. Co Manager(s)[…]